Summary

Persistence Market Research has recently released a comprehensive report on the worldwide market for Croscarmellose Sodium (CCS). The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global Croscarmellose Sodium (CCS) market from 2025 to 2032. The Croscarmellose Sodium (CCS) market is positioned for significant growth, with a projected CAGR of 5.8% from 2025 to 2032, indicating a market value increase from USD 1.3 billion in 2025 to USD 1.9 billion by 2032.

Key Insights:

• Croscarmellose Sodium (CCS) Market Size (2025E): US$288.7 Mn
• Projected Market Value (2032F): US$487.0 Mn
• Global Market Growth Rate (CAGR 2025 to 2032): 7.8%

Croscarmellose Sodium (CCS) Market - Report Scope:

Croscarmellose Sodium (CCS) is a widely used pharmaceutical excipient primarily utilized as a superdisintegrant in tablet and capsule formulations. It enhances the dissolution and bioavailability of active pharmaceutical ingredients by promoting rapid tablet disintegration in the gastrointestinal tract. The market caters to pharmaceutical manufacturers, nutraceutical companies, and specialty chemical producers, offering CCS in various grades suitable for oral solid dosage formulations. Market growth is driven by the increasing demand for generic drugs, expanding pharmaceutical production, and rising adoption of advanced drug delivery systems. In addition, the growing nutraceutical and dietary supplements industry further supports the demand for high-performance excipients such as croscarmellose sodium.

Market Growth Drivers:

The global Croscarmellose Sodium (CCS) market is propelled by several key factors, including the rapid expansion of the pharmaceutical industry and increasing production of oral solid dosage drugs worldwide. The rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and neurological conditions has increased the demand for efficient drug formulations, thereby boosting the adoption of CCS as a critical excipient. Furthermore, the growing preference for fast-disintegrating tablets and orally disintegrating dosage forms supports market growth. Technological advancements in excipient manufacturing and the development of multifunctional excipients offering improved compressibility and stability are also contributing to the expansion of the CCS market. Moreover, increasing investments in pharmaceutical R&D and generic drug manufacturing in emerging economies continue to create favorable growth prospects for the industry.

Market Restraints:

Despite promising growth prospects, the Croscarmellose Sodium (CCS) market faces challenges related to stringent regulatory requirements, fluctuations in raw material prices, and quality compliance standards. Regulatory authorities impose strict guidelines on excipient safety, manufacturing processes, and product quality, increasing operational complexities for manufacturers. Additionally, volatility in the prices of cellulose-based raw materials can impact production costs and profit margins. The presence of alternative superdisintegrants such as sodium starch glycolate and crospovidone also creates competitive pressure within the market. Furthermore, concerns related to counterfeit pharmaceutical ingredients and inconsistent supply chains in certain developing regions may hinder market growth. Addressing these challenges requires continuous innovation, robust quality assurance systems, and strategic collaborations across the pharmaceutical value chain.

Market Opportunities:

The Croscarmellose Sodium (CCS) market presents significant growth opportunities driven by advancements in pharmaceutical formulations, expanding healthcare infrastructure, and increasing focus on patient-centric drug delivery systems. The growing adoption of orally disintegrating tablets, pediatric formulations, and geriatric medicines creates substantial demand for highly efficient superdisintegrants. Furthermore, the rapid expansion of the nutraceutical and dietary supplement sectors provides new application opportunities for CCS in functional tablets and health supplements. Emerging markets in Asia Pacific, Latin America, and the Middle East offer lucrative opportunities due to rising pharmaceutical manufacturing activities and supportive government initiatives. Strategic investments in sustainable production technologies, research collaborations, and product innovation are expected to strengthen market competitiveness and support long-term growth.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Croscarmellose Sodium (CCS) market globally?
• Which product grades and applications are driving CCS adoption across pharmaceutical and nutraceutical industries?
• How are technological advancements reshaping the competitive landscape of the Croscarmellose Sodium (CCS) market?
• Who are the key players contributing to the Croscarmellose Sodium (CCS) market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global Croscarmellose Sodium (CCS) market?

Competitive Intelligence and Business Strategy:

Leading players in the global Croscarmellose Sodium (CCS) market, including Ashland Global Holdings Inc., DFE Pharma, and JRS Pharma, focus on innovation, product quality, and strategic collaborations to strengthen their market position. These companies invest significantly in research and development to introduce high-purity and multifunctional excipient solutions that meet evolving pharmaceutical industry standards. Partnerships with pharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), and regulatory agencies help facilitate product adoption and market expansion. Moreover, companies are emphasizing sustainable manufacturing practices, enhanced supply chain management, and global distribution networks to gain a competitive advantage. Continuous focus on quality certifications, compliance, and customer-centric product development is expected to drive market growth and improve long-term business sustainability.

Key Companies Profiled:

• Ashland Global Holdings Inc.
• DFE Pharma
• JRS Pharma
• Roquette Frères
• Avantor Inc.
• NB Entrepreneurs
• Maple Biotech Pvt. Ltd.
• Muby Chemicals
• Corel Pharma Chem
• Anhui Sunhere Pharmaceutical Excipients Co., Ltd.

Croscarmellose Sodium (CCS) Market Research Segmentation:

The Croscarmellose Sodium (CCS) market encompasses a diverse range of product grades, applications, and end-user segments, addressing various pharmaceutical and nutraceutical formulation requirements.

By Product Grade:

• Pharmaceutical Grade
• Food Grade
• Industrial Grade

By Application:

• Tablets
• Capsules
• Orally Disintegrating Tablets
• Nutraceutical Formulations
• Dietary Supplements
• Other Solid Dosage Forms

By End-User:

• Pharmaceutical Companies
• Nutraceutical Manufacturers
• Contract Manufacturing Organizations (CMOs)
• Research Laboratories
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Croscarmellose Sodium (CCS) Market Snapshot 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Industry Developments and Key Market Events
1.5. Demand Side and Supply Side Analysis
1.6. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definitions
2.2. Value Chain Analysis
2.3. Macro-Economic Factors
2.3.1. Global GDP Outlook
2.3.2. Global Pharmaceuticals Industry Overview
2.3.3. Global Nutraceuticals Industry Overview
2.3.4. Global Cosmetics Industry Overview
2.3.5. Global Food & Beverages Industry Overview
2.3.6. Other Macro-economic Factors
2.4. Forecast Factors - Relevance and Impact
2.5. COVID-19 Impact Assessment
2.6. PESTLE Analysis
2.7. Porter's Five Forces Analysis
2.8. Geopolitical Tensions: Market Impact
2.9. Regulatory and Technology Landscape
3. Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities
3.4. Trends
4. Price Trend Analysis, 2019 - 2032
4.1. Region-wise Price Analysis
4.2. Price by Segments
4.3. Price Impact Factors
5. Global Croscarmellose Sodium (CCS) Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
5.1. Key Highlights
5.2. Global Croscarmellose Sodium (CCS) Market Outlook: Raw Material
5.2.1. Introduction/Key Findings
5.2.2. Historical Market Size (US$ Mn) and Volume (Tons) Analysis by Raw Material, 2019-2024
5.2.3. Current Market Size (US$ Mn) and Volume (Tons) Forecast, by Raw Material, 2025-2032
5.2.3.1. Refined Wood Pulp
5.2.3.2. Cotton Linters
5.2.4. Market Attractiveness Analysis: Raw Material
5.3. Global Croscarmellose Sodium (CCS) Market Outlook: End Use
5.3.1. Introduction/Key Findings
5.3.2. Historical Market Size (US$ Mn) and Volume (Tons) Analysis by End Use, 2019-2024
5.3.3. Current Market Size (US$ Mn) and Volume (Tons) Forecast, by End Use, 2025-2032
5.3.3.1. Pharmaceutical & Nutraceutical
5.3.3.2. Food & Beverages
5.3.3.3. Cosmetics & Personal Care
5.3.3.4. Misc. (Agriculture, Textile, etc.)
5.3.4. Market Attractiveness Analysis: End Use
6. Global Croscarmellose Sodium (CCS) Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) and Volume (Tons) Analysis by Region, 2019-2024
6.3. Current Market Size (US$ Mn) and Volume (Tons) Forecast, by Region, 2025-2032
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia & Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Croscarmellose Sodium (CCS) Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. North America Market Size (US$ Mn) and Volume (Tons) Forecast, by Country, 2025-2032
7.3.1. U.S.
7.3.2. Canada
7.4. North America Market Size (US$ Mn) and Volume (Tons) Forecast, by Raw Material, 2025-2032
7.4.1. Refined Wood Pulp
7.4.2. Cotton Linters
7.5. North America Market Size (US$ Mn) and Volume (Tons) Forecast, by End Use, 2025-2032
7.5.1. Pharmaceutical & Nutraceutical
7.5.2. Food & Beverages
7.5.3. Cosmetics & Personal Care
7.5.4. Misc. (Agriculture, Textile, etc.)
8. Europe Croscarmellose Sodium (CCS) Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Europe Market Size (US$ Mn) and Volume (Tons) Forecast, by Country, 2025-2032
8.3.1. Germany
8.3.2. Italy
8.3.3. France
8.3.4. U.K.
8.3.5. Spain
8.3.6. Russia
8.3.7. Rest of Europe
8.4. Europe Market Size (US$ Mn) and Volume (Tons) Forecast, by Raw Material, 2025-2032
8.4.1. Refined Wood Pulp
8.4.2. Cotton Linters
8.5. Europe Market Size (US$ Mn) and Volume (Tons) Forecast, by End Use, 2025-2032
8.5.1. Pharmaceutical & Nutraceutical
8.5.2. Food & Beverages
8.5.3. Cosmetics & Personal Care
8.5.4. Misc. (Agriculture, Textile, etc.)
9. East Asia Croscarmellose Sodium (CCS) Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. East Asia Market Size (US$ Mn) and Volume (Tons) Forecast, by Country, 2025-2032
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.4. East Asia Market Size (US$ Mn) and Volume (Tons) Forecast, by Raw Material, 2025-2032
9.4.1. Refined Wood Pulp
9.4.2. Cotton Linters
9.5. East Asia Market Size (US$ Mn) and Volume (Tons) Forecast, by End Use, 2025-2032
9.5.1. Pharmaceutical & Nutraceutical
9.5.2. Food & Beverages
9.5.3. Cosmetics & Personal Care
9.5.4. Misc. (Agriculture, Textile, etc.)
9.6. East Asia Market Size (US$ Mn) and Volume (Tons) Forecast, by 2025-2032
10. South Asia & Oceania Croscarmellose Sodium (CCS) Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. South Asia & Oceania Market Size (US$ Mn) and Volume (Tons) Forecast, by Country, 2025-2032
10.3.1. India
10.3.2. Southeast Asia
10.3.3. ANZ
10.3.4. Rest of SAO
10.4. South Asia & Oceania Market Size (US$ Mn) and Volume (Tons) Forecast, by Raw Material, 2025-2032
10.4.1. Refined Wood Pulp
10.4.2. Cotton Linters
10.5. South Asia & Oceania Market Size (US$ Mn) and Volume (Tons) Forecast, by End Use, 2025-2032
10.5.1. Pharmaceutical & Nutraceutical
10.5.2. Food & Beverages
10.5.3. Cosmetics & Personal Care
10.5.4. Misc. (Agriculture, Textile, etc.)
11. Latin America Croscarmellose Sodium (CCS) Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
11.1. Key Highlights
11.2. Pricing Analysis
11.3. Latin America Market Size (US$ Mn) and Volume (Tons) Forecast, by Country, 2025-2032
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of LATAM
11.4. Latin America Market Size (US$ Mn) and Volume (Tons) Forecast, by Raw Material, 2025-2032
11.4.1. Refined Wood Pulp
11.4.2. Cotton Linters
11.5. Latin America Market Size (US$ Mn) and Volume (Tons) Forecast, by End Use, 2025-2032
11.5.1. Pharmaceutical & Nutraceutical
11.5.2. Food & Beverages
11.5.3. Cosmetics & Personal Care
11.5.4. Misc. (Agriculture, Textile, etc.)
12. Middle East & Africa Croscarmellose Sodium (CCS) Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
12.1. Key Highlights
12.2. Pricing Analysis
12.3. Middle East & Africa Market Size (US$ Mn) and Volume (Tons) Forecast, by Country, 2025-2032
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Northern Africa
12.3.4. Rest of MEA
12.4. Middle East & Africa Market Size (US$ Mn) and Volume (Tons) Forecast, by Raw Material, 2025-2032
12.4.1. Refined Wood Pulp
12.4.2. Cotton Linters
12.5. Middle East & Africa Market Size (US$ Mn) and Volume (Tons) Forecast, by End Use, 2025-2032
12.5.1. Pharmaceutical & Nutraceutical
12.5.2. Food & Beverages
12.5.3. Cosmetics & Personal Care
12.5.4. Misc. (Agriculture, Textile, etc.)
13. Competition Landscape
13.1. Market Share Analysis, 2024
13.2. Market Structure
13.2.1. Competition Intensity Mapping
13.2.2. Competition Dashboard
13.3. Company Profiles
13.3.1. Roquette Frères
13.3.1.1. Company Overview
13.3.1.2. Product Portfolio/Offerings
13.3.1.3. Key Financials
13.3.1.4. SWOT Analysis
13.3.1.5. Company Strategy and Key Developments
13.3.2. DFE Pharma
13.3.3. JRS Pharma
13.3.4. IFF Pharma
13.3.5. Mingtai Chemical
13.3.6. Sigachi Industries Limited
13.3.7. Accent Microcell Pvt. Ltd.
13.3.8. Alsiano A/S
13.3.9. NB Entrepreneur
13.3.10. Amster Microcell
13.3.11. Patel Chem Specialities Ltd.
13.3.12. Gangwal Healthcare Private Limited
13.3.13. Ankit Pulps and Boards Pvt. Ltd.
13.3.14. Merck Millipore
13.3.15. Jiangxi Alpha Hi-tech Pharmaceutical CO., Ltd.
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations